Podcast
How NVIDIA’s AI Platforms are Reshaping the Future of BioPharma R&D
“We can cut preclinical development from five years to 18 months. Molecules which are AI-enabled in some way seem to be doing better in Phase 1 than standard molecules.” – Dr. Eva-Maria Hempe, Head of Healthcare & Life Sciences EMEA
5 March 2025